Dr. David Clark Charles River Laboratories, UK

Dr. David E. Clark is a Senior Research Leader in Computer-aided Drug Design (CADD) at Charles River Early Discovery, having been a founding scientific member of Argenta (acquired by CRL in 2014) in August 2000. David began his career working for Proteus Molecular Design for three years where he was... read moreinvolved in developing software for de novo ligand design and protein-ligand docking. He then spent four years working in the CADD group of Aventis/Rhône-Poulenc Rorer before joining Argenta. David is a graduate of the University of Oxford where he studied chemistry. His post-graduate studies (MSc, PhD) were carried out in the Department of Information Studies at University of Sheffield under the supervision of Professor Peter Willett. In 2003, David was the recipient of the Corwin Hansch award, which is presented annually to a researcher under the age of 40 for significant contributions to the field of computational drug design. Over the course of his career, David has co-authored more than 75 scientific papers and is named as an inventor on over 40 patents.